OQY-3258, also known as ESG401, is an anti-TROP2 ADC currently under evaluation in three clinical trials: A Phase 1a/1b clinical trial for patients with solid tumors (NCT04892342). A Phase 3 study in ...

Kodiak Sciences Inc. , a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat a broad spectrum of retinal diseases, announced today ...

Nuvectis intends to use the net proceeds from this offering to continue to advance the development programs of NXP800 and NXP900 or any future product candidate, hiring of additional personnel, ...

Azitra, Inc. (NYSE American: AZTR), a clinical-stage biopharmaceutical company focused on developing innovative therapies for ...

It's been almost a month since we published Version 2.0 of our Opening Day lineup predictions on Jan. 6, and things have become much clearer as the ...

There are a handful top-notch MLB free agents still available (Alex Bregman, Pete Alonso and Jack Flaherty), as well as a bunch of 'next-tier' pitchers ...

While there is some consensus that infielder Brayden Taylor and first baseman Xavier Isaac are the Rays' next-best prospects, ...

The mobility of people, especially from the Global South, is going to be scrutinised and regulated, but it won't have much ...

Many taxpayers are eager to file returns quickly to collect refunds, but it’s important to gather the necessary tax forms first, experts say. Every year, employers and financial companies ...

Plaintiff relators' qui tam action under the False Claims Act alleged that the HCL defendants (collectively HCL)—their former ...

Sean Duffy, who was just confirmed as Secretary of Transportation on the back of the transportation “expertise” he showed as a contestant on Road Rules: All Stars, a reality TV travel game ...

Free-agent right-handed starting pitcher Max Scherzer has agreed to terms with the Toronto Blue Jays on a one-year contract will pay him $15.5 million, CBS Sports HQ's Jim Bowden has confirmed ...